CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer

By sjmartinez • March 30, 2025

Huynh JT, Li R, Shin DS. CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5):CRE25-050. doi: 10.6004/jnccn.2024.7225. PMID: 40154310.

Tags: Fellow, General Internal Medicine, Hematology/Oncology, Publications, Resident

Collagenous Gastritis Presenting as Chronic Nausea and Vomiting

Shahrvini B, Greb AC, Wang HL, Tripathi PV, Weiss GA, Myint A. Collagenous Gastritis Presenting as Chronic Nausea and Vomiting. ACG Case Rep J. 2026[...]

Crystal clear: Purity of street-level methamphetamine samples and methamphetamine-adulteration of other drugs in Los Angeles, 2023-2025

Koncsol AJ, Molina CA, Romero R, Grabill M, Godvin ME, Carrizal J, Contreras M, Arellano O, Villanueva N, Jalayer E, Davila S, Snakeoil S, Smith[...]

Widespread antibiotic resistance and multidrug resistance in Escherichia coli from surface waters near dairies and a calf ranch in Wisconsin: Implications for hotspot screening and multi-method monitoring

Osborn KP, Zhang Y, Ray S, Kong Y, Levy S, Jun S, Chang M, Lin J, Vuong J, Ives C, Jones A, Henning L, Dickerson[...]